Effect of Human Umbilical Cord Derived Mononuclear Cells Transplantation on Ovarian Dysfunction Caused by Methotrexate in Female Rats | ||||
| Suez Canal University Medical Journal | ||||
| Article 6, Volume 19, Issue 2, October 2016, Page 159-166 PDF (797.17 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/scumj.2016.116290 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Reham E Masoud  1; Amira S Mohammed2
| ||||
| 1Department of Clinical Pharmacology, Faculty of Medicine, Port Said University | ||||
| 2Department of Clinical Pharmacology, Faculty of Medicine, Suez Canal University, Egypt | ||||
| Abstract | ||||
| Background: A search for methods to prevent infertility in patients receiving chemotherapy including methotrexate is important. Cell therapies with human embryonic and specific adult stem cells have emerged as an alternative management for various diseases. Aim: To study the effect of human umbilical cord-derived mononuclear cell transplantation on ovarian dysfunction caused by methotrexate in female rats. Methods: the effect of mononuclear cells (MNCs) treatment (IV injection once in the tail vein for diabetic rats in a dose of 150 × 106 MNCs cells/rat) on ovary and uterus pathology, malondialdehyde (MDA) level in the ovary, and follicle-stimulating hormone (FSH) level was assessed after methotrexate treatment. Results: Treatment with MNCs in rats pretreated with methotrexate significantly improved all parameters measured (body weight, the ratio between ovary and body weight, the ratio between uterus and body weight), level of MDA in ovary tissue, FSH, and histopathology of ovary and uterus as compared to methotrexate only treated rats. Conclusion: These data indicate that MNCs treatment improved ovarian dysfunction associated with methotrexate therapy. | ||||
| Keywords | ||||
| FSH; follicle-stimulating hormone; MDA; malondialdehyde; chemotherapy; reproductive organs | ||||
|
Statistics Article View: 108 PDF Download: 311 |
||||
